Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2011

View Archived Issues

SPINK1 identified as potential therapeutic target in prostate cancer

GSK-3 inhibitor SC-001 may have potential for the treatment of Parkinson's disease

Neuroprotective efficacy hypothesized for Klotho enhancers

New dual DPP IV/AP-N inhibitors prepared by IMTM

Research Development Foundation patents novel urocortin-2 analogues

New B-raf inhibitors reported by Array BioPharma and Genentech

Lilly and Avid receive FDA complete response letter for Amyvid

Vardenafil plus tamsulosin improves LUTS in subjects with BPH in long-term study

CHMP recommends approval of Lucentis in new indication

Nerviano enters into oncology license agreement with Novartis

CHMP adopts negative opinion for Vectibix in combination with chemotherapy

Insys Therapeutics reports phase III data for fentanyl sublingual spray

Lonza and Athera sign development and manufacturing agreement for PC-mAb

Scientists at Anacor Pharmaceuticals prepare new antiprotozoal agents

Regeneron and sanofi-aventis begin phase II trial of MAb SAR-231893 in eosinophilic asthma

University of Pennsylvania designs novel adamantane analogues for influenza and related disorders

Euthymics Bioscience begins EB-1010 trial for major depression

KAI Pharmaceuticals begins enrollment of phase II study of KAI-4169 in secondary hyperparathyroidism

Polaris begins enrollment in phase II trial of ADI-PEG 20 in malignant mesothelioma

KineMed extends collaboration with Bristol-Myers Squibb for Alzheimer's disease

Genentech's pivotal trial of vismodegib in advanced basal cell carcinoma meets primary endpoint

CHMP adopts positive opinion regarding new birth control pill NOMAC/E2

Septodont acquires local anesthesia reversal agent OraVerse from Novalar

Quark terminates phase II study of PF-04523655 early, plans phase IIb study

Cell Therapeutics opens enrollment in pivotal PIX-R trial of pixantrone

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...